An infectious disease clinical specialist provides insight on approaching treatment of complicated UTIs and shares the impact of the COVID-19 pandemic on treatment approach as well as the importance of antimicrobial stewardship.
EP. 1: Overview of Urinary Tract Infections
Kim Leuthner, PharmD, FIDSA, provides insight on distinguishing between complicated and uncomplicated UTIs, and patients who are at high risk for developing complicated UTIs.
EP. 2: Approaching Treatment for Complicated UTIs
An infectious disease clinical specialist shares treatment considerations for patients with complicated urinary tract infections, including for patients with comorbidities and older patients, and reviews antimicrobial therapies for multidrug-resistant UTIs.
EP. 3: Impact of COVID-19 on Complicated UTIs
Kim Leuthner, PharmD, FIDSA, comments on the effect of COVID-19 on the epidemiology of complicated UTIs, the use of antibiotics, and antimicrobial resistance.
EP. 4: Optimizing Management of Complicated UTIs
An expert in infectious diseases reviews best practices for improving personalized medicine when treating complicated urinary tract infections and highlights the importance of antimicrobial stewardship.
2 Clarke Drive Cranbury, NJ 08512